Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia

Haematologica

Volumn 97, Issue 5, 2012, Pages 743-750

  Pavlaki, Konstantia I ^a   Kastrinaki, Maria Christina ^a   Klontzas, Michail ^a   Velegraki, Maria ^a   Mavroudi, Irene ^a   Papadaki, Helen A ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Age; Chronic idiopathic neutropenia; Granulocytes; Peripheral blood mononuclear cells; Telomere shortening

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGE; AGED; ARTICLE; CELL SEPARATION; CHRONIC IDIOPATHIC NEUTROPENIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; NEUTROPENIA; NEUTROPHIL COUNT; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE SHORTENING;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DNA; FEMALE; GRANULOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUTROPENIA; REAL-TIME POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE SHORTENING;

EID: 84860573072     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.053983     Document Type: Article

References (45)

1. Dale DC, Guerry D, Wewerka JR, Bull JM, Chusid MJ. Chronic neutropenia. Medicine (Baltimore). 1979;58(2):128-144.
2. Papadaki HA, Palmblad J, Eliopoulos GD. Non-immune chronic idiopathic neutropenia of adult: an overview. Eur J Haematol. 2001;67(1):35-44.
3. Papadaki HA, Eliopoulos AG, Kosteas T, Gemetzi C, Damianaki A, Koutala H, et al. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood. 2003;101(7):2591-2600.
4. Papadaki HA, Giouremou K, Eliopoulos GD. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-beta1 by bone marrow stromal cells. Eur J Haematol. 1999;63(3):154-162.
5. Mavroudi I, Papadaki V, Pyrovolaki K, Katonis P, Eliopoulos AG, Papadaki HA. The CD40/CD40 ligand interactions exert pleiotropic effects on bone marrow granulopoiesis. J Leukoc Biol. 2011;89(5):771-783.
6. Velegraki M, Kanellias N, Mavroudi I, Eliopoulos G, Papadaki HA. Toll-like receptor 4 activation in the bone marrow of patients with chronic idiopathic neutropenia may contribute to the inflammatory marrow environment. Haematologica. 2008;93 (S1):235.
7. Spanoudakis M, Koutala H, Ximeri M, Pyrovolaki K, Stamatopoulos K, Papadaki HA. T-cell receptor Vbeta repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions. Clin Immunol. 2010; 137(3):384-395.
8. Papadaki HA, Stamatopoulos K, Damianaki A, Gemetzi C, Anagnostopoulos A, Papadaki T, et al. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br J Haematol. 2005;128(6):863-876.
9. Palmblad J, Papadaki HA. Chronic idiopathic neutropenias and severe congenital neutropenia. Curr Opin Hematol. 2008;15(1):8-14.
10. Papadaki HA, Pontikoglou C. Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia. Expert Rev Hematol. 2008;1(2):217-229.
11. Papadaki HA, Eliopoulos DG, Valatas V, Eliopoulos GD. Anemia of chronic disease is the more frequent type of anemia seen in patients with chronic idiopathic neutropenia of adults. Ann Hematol. 2001;80(4):195-200.
12. Psyllaki M, Damianaki A, Gemetzi C, Pyrovolaki K, Eliopoulos GD, Papadaki HA. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow. Br J Haematol. 2006;134(6):624-631.
13. Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001;97(4):895-900.
14. Karadimitris A, Araten DJ, Luzzatto L, Notaro R. Severe telomere shortening in patients with paroxysmal nocturnal hemoglobinuria affects both GPI- and GPI+ hematopoiesis. Blood. 2003;102(2):514-516.
15. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res. 1994;54(13):3557-3560.
16. Savage SA, Alter BP. The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev. 2008;129(1- 2):35-47.
17. Drummond MW, Balabanov S, Holyoake TL, Brummendorf TH. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells. Stem Cells. 2007;25(8):1853-61.
18. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10):e47.
19. Grisham MB, Engerson TD, McCord JM, Jones HP. A comparative study of neutrophil purification and function. J Immunol Methods. 1985;82(2):315-20.
20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266 (5193):2011-5.
21. Emrich T, Karl G. Nonradioactive detection of telomerase activity using a PCR-ELISAbased telomeric repeat amplification protocol. Methods Mol Biol. 2002;191:147-58.
22. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, et al. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer. 1999;80(6):804-9.
23. Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H, Ueda N. Telomerase components as a diagnostic tool in human oral lesions. Int J Cancer. 1999;80(1):1-4.
24. Kastrinaki MC, Sidiropoulos P, Roche S, Ringe J, Lehmann S, Kritikos H, et al. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis. 2008;67(6):741-9.
25. Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Christensen K, Wadsworth L, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med. 1999;190(2):157-67.
26. Robertson JD, Gale RE, Wynn RF, Dougal M, Linch DC, Testa NG, et al. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br J Haematol. 2000;109(2):272-9.
27. Weng N. Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J Leukoc Biol. 2001; 70(6):861-7.
28. Gemetzi C, Mavroudi I, Koutala H, Velegraki M, Choulaki C, Damianaki A, et al. Lymphopenia in patients with chronic idiopathic neutropenia is associated with decreased number of T-lymphocytes containing T-cell receptor excision circles. Eur J Haematol. In press.
29. Uchida N, Otsuka T, Shigematsu H, Maeda M, Sugio Y, Itoh Y, et al. Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells. Leuk Res. 1999;23(12): 1127-32.
30. Otsuka T, Uchida N, Arima F, Shigematsu H, Fukuyama T, Maeda M, et al. Down-regulation of human telomeric protein TRF1 gene expression during myeloid differentiation in human hematopoietic cells. Int J Hematol. 2000;71(4):334-9.
31. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995;155(8):3711-5.
32. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC. Progressive telomere shortening in aplastic anemia. Blood. 1998;91(10):3582-92.
33. Rigolin GM, Porta MD, Bugli AM, Castagnari B, Mauro E, Bragotti LZ, et al. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings. Eur J Haematol. 2004;73(5):351-8.
34. Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med. 2005;352(14):1413-24.
35. Savage SA, Calado RT, Xin ZT, Ly H, Young NS, Chanock SJ. Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia. Exp Hematol. 2006;34(5):664-71.
36. Calado RT, Young NS. Telomere maintenance and human bone marrow failure. Blood. 2008;111(9):4446-55.
37. Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009;361(24):2353-65.
38. Burns JB, Lobo ST, Bartholomew BD. In vivo reduction of telomere length in human antigen- reactive memory T cells. Eur J Immunol. 2000;30(7):1894-901.
39. Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res. 1997;231(2): 346-53.
40. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002;27(7): 339-44.
41. Uziel O, Reshef H, Ravid A, Fabian I, Halperin D, Ram R, et al. Oxidative stress causes telomere damage in Fanconi anaemia cells - a possible predisposition for malignant transformation. Br J Haematol. 2008; 142(1):82-93.
42. Marcondes AM, Ramakrishnan A, Deeg HJ. Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS. Curr Cancer Ther Rev. 2009;5(4):310-4.
43. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413(6854):432-5.
44. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36(5):447-9.
45. Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet AS, et al. The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev. 2010;9(10): 646-51.